Tag Archives: generics
Biosimilars: How the EMEA Got It Right (Part 1)
I don’t think anyone disagrees that: Access to life-saving medications for all patients must be granted through a patient-focused, science-based application of a logical, open, and rational process, and that For patients to gain the greatest possible benefits, biologics with … Continue reading
Filed under Biosimilars Legislation
Hatch-Waxman 25 years later…lots o’ (the same) cheap drugs
25 years on, was Hatch-Waxman such a great idea? Dried-up small-molecule pipelines, the endless search for blockbusters at the expense of innovation, in-licensing from smaller innovative companies–just what you’d expect from a law that had the unintended effect of shutting down innovation. Continue reading
Filed under Pharmaceutical legislation
